Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kenneth Watanabe"'
Autor:
Chuan He, Yuan Li, Ming Yue, Li Chen, Michelle M. Le Beau, Richard A. Larson, John Anastasi, Qingxi J. Shen, James W. Vardiman, Jamile M. Shammo, Jiangbo Wei, Kenneth Watanabe, Adam Cloe, Jason X. Cheng
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-16 (2018)
The roles of RNA 5-methylcytosine (RNA:m5C) and RNA:m5C methyltransferases (RCMTs) in lineage-associated chromatin organization and drug response/resistance are unclear. Here we demonstrate that the RCMTs, namely NSUN3 and DNMT2, directly bind hnRNPK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0434e899b25b2706b61a51df01fb55a7
http://link.springer.com/article/10.1038/s41467-018-03513-4
http://link.springer.com/article/10.1038/s41467-018-03513-4
Autor:
Adam Cloe, James W. Vardiman, Li Chen, Chuan He, Kenneth Watanabe, Richard A. Larson, Qingxi J. Shen, Jason X. Cheng, Jamile M. Shammo, Yuan Li, Michelle M. Le Beau, John Anastasi, Jiangbo Wei, Ming Yue
Publikováno v:
Nature Communications
Nature Communications, Vol 9, Iss 1, Pp 1-1 (2018)
Nature Communications, Vol 9, Iss 1, Pp 1-1 (2018)
The roles of RNA 5-methylcytosine (RNA:m5C) and RNA:m5C methyltransferases (RCMTs) in lineage-associated chromatin organization and drug response/resistance are unclear. Here we demonstrate that the RCMTs, namely NSUN3 and DNMT2, directly bind hnRNPK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80a7e70f49b143d028c18266bbace12a
https://pubmed.ncbi.nlm.nih.gov/29563491
https://pubmed.ncbi.nlm.nih.gov/29563491
Autor:
Michael R. Freeman, Sungyong You, Nitya V. Sharma, Kenneth Watanabe, Karen N. Conneely, Carlos S. Moreno, Adeboye O. Osunkoya, Felipe O. Giuste, Fred Saad, S.S. Ramalingam, Anne-Marie Mes-Masson, Dominique Trudel, Veronique Ouellet, John A. Petros, Paula M. Vertino, Lucresse Fossouo, Kathryn L. Pellegrini, Eloise Adam-Granger
Publikováno v:
Cancers
Volume 10
Issue 10
Cancers, Vol 10, Iss 10, p 379 (2018)
Volume 10
Issue 10
Cancers, Vol 10, Iss 10, p 379 (2018)
Background: Patients with locally advanced or recurrent prostate cancer typically undergo androgen deprivation therapy (ADT), but the benefits are often short-lived and the responses variable. ADT failure results in castration-resistant prostate canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d900f25dfb8662920c8966eb746f6141
https://doi.org/10.3390/cancers10100379
https://doi.org/10.3390/cancers10100379
Autor:
Paula M. Vertino, Veronique Ouellet, Kathryn L. Pellegrini, Adeboye O. Osunkoya, Eloise Adam-Granger, Kenneth Watanabe, Fred Saad, Anne-Marie Mes-Masson, Sungyong You, Michael R. Freeman, Carlos S. Moreno, Lucresse Fossouo, Nitya V. Sharma, Karen N. Conneely, John A. Petros, S.S. Ramalingam, Dominique Trudel, Felipe O. Giuste
Publikováno v:
Cancer Research. 78:2269-2269
Patients with recurrent, aggressive prostate cancer typically undergo androgen-deprivation therapy (ADT), but the benefits are often short-lived, and responses are variable. Failure to respond to ADT invariably leads to metastatic disease, and ultima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc65a497bf1ae21cc1d22d3f347dede4
https://doi.org/10.1158/1538-7445.am2018-2269
https://doi.org/10.1158/1538-7445.am2018-2269
Autor:
Jeffery Q. Shen, James W. Vardiman, Randall Knibbs, Kenneth Watanabe, Erica L. Kleinbrink, Edward Grimley, Jason X. Cheng, John Anastasi
Publikováno v:
American Journal of Clinical Pathology. 138:A338-A338
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1265cb81d866bf14c09cdf9e41f65121
https://doi.org/10.1093/ajcp/138.suppl2.120
https://doi.org/10.1093/ajcp/138.suppl2.120